CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced that it will provide an overview of its drug discovery and development programs targeted to Toll-like Receptors and a general corporate update at the Cowen and Company 31st Annual Health Care Conference on Monday, March 7, 2011 at 10:35 a.m. ET at the Boston Marriott Copley Place in Boston, MA.
